Annual ROE
-35.33%
-13.54%-62.14%
December 31, 2023
Summary
- As of February 7, 2025, TERN annual return on equity is -35.33%, with the most recent change of -13.54% (-62.14%) on December 31, 2023.
- During the last 3 years, TERN annual ROE has risen by +23.06% (+39.49%).
- TERN annual ROE is now -62.14% below its all-time high of -21.79%, reached on December 31, 2022.
Performance
TERN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-32.76%
+6.82%+17.23%
September 30, 2024
Summary
- As of February 7, 2025, TERN quarterly return on equity is -32.76%, with the most recent change of +6.82% (+17.23%) on September 30, 2024.
- Over the past year, TERN quarterly ROE has increased by +0.79% (+2.35%).
- TERN quarterly ROE is now -108.47% below its all-time high of 386.60%, reached on September 30, 2020.
Performance
TERN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TERN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.1% | +2.4% |
| 3 y3 years | +39.5% | +2.4% |
| 5 y5 years | -44.1% | +2.4% |
TERN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.1% | +19.4% | -16.2% | +17.2% |
| 5 y | 5-year | -62.1% | +97.8% | -108.5% | +95.2% |
| alltime | all time | -62.1% | +97.8% | -108.5% | +95.2% |
Terns Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -32.76%(-17.2%) |
| Jun 2024 | - | -39.58%(+11.3%) |
| Mar 2024 | - | -35.55%(+6.0%) |
| Dec 2023 | -35.33%(+62.1%) | -33.55%(+8.3%) |
| Sep 2023 | - | -30.99%(+9.9%) |
| Jun 2023 | - | -28.19%(-8.4%) |
| Mar 2023 | - | -30.76%(-4.9%) |
| Dec 2022 | -21.79% | -32.33%(-13.4%) |
| Sep 2022 | - | -37.32%(+7.3%) |
| Jun 2022 | - | -34.79%(+13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -30.55%(+7.2%) |
| Dec 2021 | -43.83%(-24.9%) | -28.51%(-4.8%) |
| Sep 2021 | - | -29.96%(-31.6%) |
| Jun 2021 | - | -43.79%(-23.1%) |
| Mar 2021 | - | -56.97%(-68.9%) |
| Dec 2020 | -58.39%(-96.4%) | -183.12%(-147.4%) |
| Sep 2020 | - | 386.60%(-157.1%) |
| Jun 2020 | - | -676.59%(+51.6%) |
| Mar 2020 | - | -446.30%(+92.1%) |
| Dec 2019 | -1630.88%(+6551.2%) | -232.35% |
| Dec 2018 | -24.52% | - |
FAQ
- What is Terns Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual ROE year-on-year change?
- What is Terns Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly ROE year-on-year change?
What is Terns Pharmaceuticals annual return on equity?
The current annual ROE of TERN is -35.33%
What is the all time high annual ROE for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual return on equity is -21.79%
What is Terns Pharmaceuticals annual ROE year-on-year change?
Over the past year, TERN annual return on equity has changed by -13.54% (-62.14%)
What is Terns Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TERN is -32.76%
What is the all time high quarterly ROE for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly return on equity is 386.60%
What is Terns Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TERN quarterly return on equity has changed by +0.79% (+2.35%)